Catalyst Wire Dossier Catalyst Wire Dossier

Foscarbidopa

foscarbidopa · AbbVie
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Foscarbidopa, covering 2025-09-08 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

See pricing